Entac Medical Inc., a Memphis, Tenn-based predictive analytics company developing noninvasive devices for the prediction and diagnosis of gastrointestinal and other medical conditions, raised Series A funding of undisclosed amount.
The round, which remains open until January 31, 2016, was led by Innova Memphis, with participation from Angel Syndicates Central, an angel syndicate located in Huntsville, AL and the Angel Round Table of Johnson City, TN.
The company intends to use the funds to complete development of PrevisEA, its non invasive, patented technology which detects a biological signal that is highly correlated with the development of gastrointestinal impairment (GII); primarily postoperative ileus, an acute paralysis of the gastrointestinal tract causing nausea and vomiting, abdominal distention and pain.
Led by Buddy Lyons, CEO, Entac is also planning additional applications of the platform technology in gastrointestinal predictive medicine and diagnostics.
FinSMEs
05/01/2016